During the AGM, Don said they’d applied for a new patent on the basis of BETonMACE. Whatever it is, they wasted no time. Could it be to do with an effect on cognitive function? The embargo extension to the end of March requested by some investigators, which Don mentioned towards the end of his talk, might have been to wait for the World Congress on Neuroscience and Brain Disorders, London, 23-24 March. If so, it would suggest they think the results worthy of a bigger meeting than the Alzheimer’s in December. Academics generally prefer to present their most exciting data at the biggest international conferences even if it means bypassing earlier opportunities to do so at smaller meetings.

Only speculation on my part, but food for thought!